For GLP-1 receptor agonists specifically, adherence challenges are a major concern, as these medications require long-term use to achieve meaningful health benefits in chronic conditions like diabetes and obesity.
The post The Role of Medication Delivery in Non-Adherence appeared first on MedCity News.
